Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fanghänel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 7, 2000
A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesityG Fanghänel, L Cortinas, L Sánchez-Reyes, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 22, 2001
Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-overG Fanghänel, L Cortinas, L Sánchez-Reyes, et al.
Obesity Research|May 2, 2001
Evolution of the prevalence of obesity in the workers of a general hospital in MexicoG Fanghänel, L Sánchez-Reyes, A Berber, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 10, 2002
Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican populationA Berber, R Gómez-Santos, G Fanghänel, et al.
Diabetes Care|November 1, 1996
Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureasG Fanghänel, L Sánchez-Reyes, C Trujillo, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|January 1, 1993
ACTH secreting pituitary microadenomas disclosed only by gadolinium DTPA enhanced MRIB Boleaga, G Fanghänel, L Cortinas, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|February 9, 1999
Effects of metformin on fibrinogen levels in obese patients with type 2 diabetesG Fanghänel, U Silva, L Sanchez-Reyes, et al.
Archives of Medical Research|January 15, 1999
Comparative accuracy of glucose monitorsG Fanghänel, L Sanchez-Reyes, M Morales, et al.
Archivos Del Instituto De Cardiologia De Mexico|March 1, 1996
[The efficacy, safety and tolerance of fluvastatin sodium 40 mg in patients with hyperlipidemia type IIA]G Fanghänel Salmón, J L Salgado Loza, L Sánchez Reyes, et al.
The American Journal of Cardiology|July 13, 1995
Open-label study to assess the efficacy, safety, and tolerability of fluvastatin versus bezafibrate for hypercholesterolemiaG Fanghänel, J Espinosa, D Olivares, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 7, 2000
A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesityG Fanghänel, L Cortinas, L Sánchez-Reyes, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 22, 2001
Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-overG Fanghänel, L Cortinas, L Sánchez-Reyes, et al.
Obesity Research|May 2, 2001
Evolution of the prevalence of obesity in the workers of a general hospital in MexicoG Fanghänel, L Sánchez-Reyes, A Berber, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 10, 2002
Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican populationA Berber, R Gómez-Santos, G Fanghänel, et al.
Diabetes Care|November 1, 1996
Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureasG Fanghänel, L Sánchez-Reyes, C Trujillo, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|January 1, 1993
ACTH secreting pituitary microadenomas disclosed only by gadolinium DTPA enhanced MRIB Boleaga, G Fanghänel, L Cortinas, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|February 9, 1999
Effects of metformin on fibrinogen levels in obese patients with type 2 diabetesG Fanghänel, U Silva, L Sanchez-Reyes, et al.
Archives of Medical Research|January 15, 1999
Comparative accuracy of glucose monitorsG Fanghänel, L Sanchez-Reyes, M Morales, et al.
Archivos Del Instituto De Cardiologia De Mexico|March 1, 1996
[The efficacy, safety and tolerance of fluvastatin sodium 40 mg in patients with hyperlipidemia type IIA]G Fanghänel Salmón, J L Salgado Loza, L Sánchez Reyes, et al.
The American Journal of Cardiology|July 13, 1995
Open-label study to assess the efficacy, safety, and tolerability of fluvastatin versus bezafibrate for hypercholesterolemiaG Fanghänel, J Espinosa, D Olivares, et al.
Pageof 2